Related Experiment Video
Updated: Aug 26, 2026

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
Topical antibiotics: strategies for avoiding ototoxicity
1Department of Hearing and Speech Sciences, Vanderbilt Bill Wilkerson Center, Vanderbilt University Medical Center, Nashville, USA.
Abstract:
As we continue to learn more about ototoxicity from ototopical drugs, there are several key points we must keep in mind: Aminoglycoside antibiotics used in ototopical agents do have ototoxic potential. Reported cases of ototoxicity are relatively uncommon, but the potential for serious complications does exist. Subclinical unilateral vestibular deficits do go unrecognized. Superior alternatives to aminoglycoside drops, particularly the quinolone drops, are readily available. The quinolones are superior to the aminoglycosides in terms of safety, bacterial eradication, and clinical cure and are therefore the drops of choice for treating otorrhea in an open infected ear.
Insights
Aminoglycoside ear drops can cause ototoxicity, potentially leading to serious complications. Quinolone drops offer a safer and more effective alternative for treating ear infections.
Area of Science:
- Ototoxic potential of topical medications
- Otolaryngology
- Pharmacology
Background:
- Topical aminoglycoside antibiotics carry a risk of ototoxicity.
- While uncommon, ototoxicity from these agents can result in severe complications.
- Subclinical vestibular deficits often remain undiagnosed.
Purpose of the Study:
- To highlight the ototoxic risks associated with topical aminoglycosides.
- To advocate for the use of safer alternatives in treating otorrhea.
- To compare the efficacy and safety of quinolone versus aminoglycoside ear drops.
Main Methods:
- Review of ototoxicity literature concerning topical ear medications.
- Comparative analysis of aminoglycoside and quinolone ear drops.
- Clinical outcomes assessment for otorrhea treatment.
Main Results:
- Aminoglycosides possess ototoxic potential, with risks including subclinical vestibular deficits.
- Quinolone ear drops demonstrate superior safety profiles compared to aminoglycosides.
- Quinolones show enhanced bacterial eradication and clinical cure rates.
Conclusions:
- Quinolone ear drops are the preferred choice for treating otorrhea in open infected ears.
- The shift from aminoglycosides to quinolones improves patient safety and treatment outcomes.
- Awareness of ototoxicity risks is crucial when using ototopical drugs.
More Related Videos
12:21The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
Published on: November 26, 2015
09:18A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection
Published on: March 8, 2017
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Pharmaceutical Poisoning: Treatment Strategies
Antifungal Agents
Local Anesthetics: Common Agents and Their Applications
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
Hand hygiene
Hand washing...